ethionamide
Also known as 1314 TH, ETP, ETH, 2-ethylthioisonicotinamide, etionamide, ethylisothiamide, 2-ethyl-4-thiopyridylamide
Ethionamide (aka ETA or ETH) is an antibiotic used to treat tuberculosis. Specifically it is used, along with other antituberculosis medications, to treat active multidrug-resistant tuberculosis. It is no longer recommended for leprosy. It is taken by mouth.
Chemical data
- Formula
- C8H10N2S
- Molecular weight
- 166.25 g/mol
- IUPAC name
- 2-ethylpyridine-4-carbothioamide
- SMILES
- CCC1=NC=CC(=C1)C(=S)N
- InChIKey
- AEOCXXJPGCBFJA-UHFFFAOYSA-N
- XLogP
- 1.1
- Polar surface area
- 71 Ų
- H-bond donors
- 1
- H-bond acceptors
- 2
- Formal charge
- 0
via PubChem
Research
1,881 papersArticle
13 sectionsContents
- Medical uses
- Microbial resistance
- Adverse effects
- Hepatotoxicity
- Neurotoxicity
- Thyrotoxicity
- Interactions
- Pharmacology
- Pharmacodynamics
- Pharmacokinetics
- Other names
- References
- External links
Ethionamide (aka ETA or ETH) is an antibiotic used to treat tuberculosis. Specifically it is used, along with other antituberculosis medications, to treat active multidrug-resistant tuberculosis. It is no longer recommended for leprosy. It is taken by mouth.
Ethionamide has a high rate of side effects. Common side effects include nausea, diarrhea, abdominal pain, and loss of appetite. Serious side effects may include liver inflammation and depression. It should not be used in people with significant liver problems. Use in pregnancy is not recommended as safety is unclear. Ethionamide is in the thioamides family of medications. It is believed to work by interfering with the use of mycolic acid.